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Drug targetATP synthase is a ubiquitous enzyme that is largely conserved across the kingdoms of life. This conservation is in
accordancewith its central role in chemiosmotic energy conversion, a pathway utilized by far bymost living cells.
On the other hand, in particular pathogenic bacteria whilst employing ATP synthase have to deal with energeti-
cally unfavorable conditions such as low oxygen tensions in the human host, e.g.Mycobacterium tuberculosis can
survive in human macrophages for an extended time. It is well conceivable that such ATP synthases may carry
idiosyncratic features that contribute to efﬁcient ATP production. In this review genetic and biochemical data
on mycobacterial ATP synthase are discussed in terms of rotary catalysis, stator composition, and regulation of
activity. ATP synthase in mycobacteria is of particular interest as this enzyme has been validated as a target for
promising new antibacterial drugs. A deeper understanding of the working of mycobacterial ATP synthase and
its atypical features can provide insight in adaptations of bacterial energy metabolism. Moreover, pinpointing
and understanding critical differences as compared with human ATP synthase may provide input for the design
and development of selective ATP synthase inhibitors as antibacterials. This article is part of a Special Issue enti-
tled: 18th European Bioenergetic Conference.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
ATP synthase is a ubiquitous key enzyme in energy metabolism of
virtually all living cells. The enzyme utilizes the energy stored in a
trans-membrane electrochemical potential difference of a coupling ion
for production of ATP. Bacterial ATP synthase is composed of a
membrane-embedded Fo sector with subunit composition a1b2c10–15
and a hydrophilic F1 part, consisting of subunits α3β3γδε (Fig. 1A). In
mitochondrial ATP synthase several more peripheral subunits are
found in addition to the eight core subunits also present in bacteria
(Fig. 1B) (for review see [1–3].
Passage of ions, inmost cases protons, through Fo triggers rotation of
the oligomeric subunit c ring, which is coupled to rotation of subunit γ
and subunit ε. Rotation of subunit γ within the α3β3 hexamer of F1 in
turn drives synthesis of ATP [4–8]. While the basic structure of ATP syn-
thase and its mechanism of rotary catalysis apparently are conserved
across the three kingdoms of life, ATP synthases from certain organisms
show specialized features thatmay represent adaptations to speciﬁc en-
vironments encountered. As an example, ATP synthases fromphotosyn-
thetic organisms carry an inserted sequence of some 35 amino acids in
subunit γ, which allows for redox regulation, adjusting the enzyme's
activity to the available light intensity [9–11]. ATP synthase fromopean Bioenergetic Conference.
1 205987136.
ights reserved.thermoalkaliphilic bacteria displays conserved basic residues in subunit
a, facilitating capture and ﬂow of protons under alkaline conditions [12].
ATP synthesis in pathogenic bacteria may face exceptional chal-
lenges, as a variety of pathogens need to deal with “low energy” condi-
tions, such as low oxygen tensions and/or nutrient limitation, e.g. in
remote parts of the human lungs or inside phagosomes of human mac-
rophages. In particularMycobacterium tuberculosis and related strains of
theMycobacterium genus, such asM. leprae andM. ulcerans, can reside
in the human host for many years [13,14]. These mycobacterial strains
can further shift-down their metabolism entering a so-called dormant
state. In this dormant state bacterial replication virtually ceases, cell
wall thickness is increased, protein and nucleic acid syntheses are sig-
niﬁcantly down-regulated, and lipid metabolism appears to be the pri-
mary energy source [15,16]. Typically, dormant mycobacteria display
only very low susceptibility towards currently used antibacterials
[17–20]. Specialized niches in which mycobacteria reside may require
adaptations in the energy metabolism in order to provide sufﬁcient
amounts of ATP and/or to generate a proton motive force (PMF)
[19,21]. As such, ATP synthase in these bacteria may carry special fea-
tures facilitating survival under conditions encountered in the human
host.
ATP synthase is reported to be essential inM. tuberculosis for optimal
growth [22] and in the non-pathogenic model strain Mycobacterium
smegmatis [23]. Likely, the essentiality stems from a need for ATP syn-
thase for production of ATP and/or for maintenance of a minimal level
of respiratory electron ﬂow [19,24]. For M. tuberculosis, a PMF of
−110 mV has been reported, with the membrane potential and the
Fig. 1. Subunit composition of ATP synthase. (A) “Standard” composition of bacterial ATP synthase, as found in E. coli. (B) ATP synthase from humanmitochondria, several small subunits
such as e, f, g, and 6 L are not shown (C) ATP synthase inmycobacteria. InM. tuberculosis, ATP synthase comprises a fusion of subunits b and subunit δ and a second, shorter, b′-type subunit
in the stator stalk. A C-terminal helix in subunit ε is lacking. The oligomeric state of the c-ring is unknown, it likely consists of N10 monomers.
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PMF of ~−200mV is found. The low PMF inM. tuberculosis likely repre-
sents an adaptation to low nutrient and/or electron acceptor availabili-
ty. ATP synthase is essential not only in replicating mycobacteria, but
also in the dormant state [18,25].
ATP synthase inM. tuberculosis has recently been validated as a high-
ly promising target of antibacterials. Its activity is efﬁciently blocked by
the diarylquinoline class of drugs [26–28]. A deeper understanding of
ATP synthase function in mycobacteria may thus not only shed light
on molecular adaptations allowing for survival under conditions of
low energy supply, but also allow for utilizing differences inmycobacte-
rial ATP synthase as compared with the human homologue for the de-
sign and development of new drug candidates.
2. Regulation of mycobacterial ATP synthase
Mycobacterial ATP synthase (Fig. 1C) is similar to other, homolo-
gous, bacterial ATP synthases regarding the subunit composition and
the ability to reversibly separate into F1 and Fo parts [29–32]. In the
catalytic core (α3β3) the sequences of subunits α and β, which house
the nucleotide binding sites, are largely conserved in mycobacteria as
compared with the homologue in E. coli and human mitochondria, re-
spectively. Subunit α from M. tuberculosis displays 52% and 55% se-
quence identity compared with the homologue in E. coli and human
mitochondria, respectively, the corresponding values for subunit β are
59% and 61%. Functional sequence motifs typically found in F1-ATPases
are conserved in mycobacteria, such as the P-loop for nucleotide bind-
ing (βG171–T178 inM. tuberculosis), the acidic residue acting as nucle-
ophile for the ATP hydrolysis reaction (βE183) [5], the DELSEED
sequence (βD403–D409) for torque transmission [33], and the arginine
ﬁnger involved in stabilization of the ATP hydrolysis transition state
(αR376) [5,34,35] (for sequence alignments of subunitsα and β please
see Supplementary Figs. 1 and 2). The main differences likely are not
found in the central catalytic mechanism of ATP synthesis or hydrolysis,
but are associated with the regulation of ATP synthase activity.
Synthesis of ATP is in principle reversible; under conditions of low
PMF many ATP synthases can catalyze hydrolysis of ATP, yielding ADP
and inorganic phosphate, thereby pumping protons across the
membrane. Some bacteria can use this reversed reaction to maintain
the PMF under energetically unfavorable conditions, whereas in certain
other bacteria this inversion of function is blocked [36]. In ATP synthase
from chloroplasts and mitochondria, elaborate regulatory mechanisms
suppress hydrolysis of ATP [3,10]. In mycobacteria pronounced
suppression of the ATP hydrolysis function has been reported for
M. phlei [29], forM. smegmatis [37] and forM. bovis BCG [37]. The latent
ATP hydrolysis activity by inverted membrane vesicles ofM. smegmatis
and M. bovis BCG could be activated, in particular by transient
membrane energization [37]. M. bovis BCG and M. smegmatis are non-
pathogenic mycobacterial strains widely used as model systems forM. tuberculosis. Suppression of ATP hydrolysis activity appears to be a
general feature in mycobacteria, found both in strains residing in mam-
malian hosts, such as M. tuberculosis and M. bovis, as well as in sapro-
phytic strains, such as M. smegmatis. For M. tuberculosis and other
pathogenicmycobacterial strains blocking of ATP hydrolysis is of partic-
ular interest as it may represent an adaptation to its “lifestyle” in and
outside human phagosomes, where ATP, once produced, must not be
wasted.
2.1. Regulation by Mg-ADP
Suppression of ATP hydrolysis activity can be due tomultiple factors,
such as inhibitory binding of Mg-ADP, inhibition by subunit ε, or by
binding of additional effectors, such as the inhibitory protein subunit
ζ. Mg-ADP inhibition can occur during hydrolysis of ATP, when the
produced ADP does not dissociate from the enzyme, but becomes
entrapped in a catalytic nucleotide binding site [38–42]. Mg-ADP inhibi-
tion is found in ATP synthases from a broad range of organisms and
can be relieved by proton motive force [43–45]. The PMF may relieve
Mg-ADP inhibition bymoving subunit γ away from its position arrested
by Mg-ADP [46–48]. Mg-ADP inhibition can also be relieved by binding
of ATP to the non-catalytic nucleotide binding sites, which are located
mainly in the α-subunits [5,49–51]. As such, Mg-ADP inhibition is an
important regulatory feature of the ATP hydrolysis reaction, in particu-
lar under circumstances of low ATP concentrations.
The observed strong suppression of ATP hydrolysis in mycobacteria
may thus be an intrinsic feature of the catalytic core (α3β3γ), caused by
pronounced Mg-ADP inhibition. Residues pinpointed as important for
ATP binding to the non-catalytic sites in other species, such as αK175,
αT176, αD261 and αD262 in Bacillus PS3 [49–52] are conserved be-
tween E. coli, Bacillus PS3 and mycobacteria, (αK178, αT179, αD272,
αD273 in M. tuberculosis), indicating no specialized adaptations in
mycobacteria in this regard. Moreover, βT165, the C-terminal residue
of the P-loop in the catalytic site, for which a role in release of inhibitory
ADP has been reported [53], is conserved (βT178 in M. tuberculosis).
Two tyrosine and one arginine residue in subunit α, which are thought
to form a link between catalytic and non-catalytic sites in Bacillus PS3
[54], are conserved in mycobacteria (αY241, αY303 and αR307 in
M. tuberculosis).
Previously, mutation studies in Schizosaccharomyces pombe sug-
gested a role of αQ173 and βQ170 in facilitating nucleotide binding to
the non-catalytic sites [55]. αQ173 and the adjacent αR172 are also
thought to contact residues in neighboring β subunits (βT354 and
βD352 respectively), thereby stabilizing the α/β interface and contrib-
uting to crosstalk between catalytic and non-catalytic nucleotide bind-
ing sites [55]. In mycobacteria, αQ173 is replaced by a lysine (αK175
in M. tuberculosis), potentially enhancing formation of a salt bridge to
a bound nucleotide, whereas βD352 is replaced by an alanine (βA361
inM. tuberculosis), possibly preventing formation of a salt bridge with
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these polymorphisms for crosstalk between nucleotide binding sites
and concomitantly on control of Mg-ADP inhibition in mycobacteria
need to be investigated. In this regard, functional experiments on
over-expressed and puriﬁed α3β3γ from mycobacterial species in
order to reveal the extent of Mg-ADP inhibition in the catalytic core
are lacking.
As compared with the homologous E. coli and Bacillus PS3 sequence,
mycobacterial subunit α carries an insertion of eight residues, βN192-
K199. Moreover, the C-terminus displays an extension of 35 amino
acid residues, αT514-K548 in M. tuberculosis. The potential inﬂuence
of these extensions, if any, on function, regulation or stabilization ofmy-
cobacterial ATP synthase is not known.
2.2. Regulation by subunit ε
The inability of mycobacterial ATP synthase to hydrolyze ATP may
alternatively be due to inhibition by subunit ε, known as a key regulator
of the ATP synthase complex [56,57]. This subunit consists of an
N-terminal β-barrel domain and a C-terminal helical domain [58]. The
two carboxy terminal α helices can either fold into a compact form,
referred to as hairpin state [58–60], or can adopt an extended con-
formation [61,62] (Fig. 2A). The reversible transition between these
two conformations constitutes a key element for regulation of ATP
hydrolysis activity. Subunit ε in the extended conformation suppresses
ATP hydrolysis (but not ATP synthesis) activity, whereas the hairpin
conformation is not inhibitory [63–74]. In the extended state the
C-terminal helices, which carry a strongly positive charge mainly due
to the presence of arginine residues [75], can interact with the negative-
ly charged DELSEED sequence in subunit β, acting as a brake arresting
rotary catalysis [76]. The crystal structure of E. coli F1-ATPase with sub-
unit ε in the extended state revealed the interaction of the C-terminal
helices with subunits α, β and γ [62,77]. The helix at the C-terminal
tip (residues ε115–133 in E. coli) deeply inserts into the central cavity
of theα3β3 hexamerwhereas the secondhelix binds to theDELSEED se-
quence. As such, the helical domain interacts with the catalytic sites in
subunits β and can execute its intrinsic inhibitory effect on ATP hydro-
lysis activity [62].
Transition between the two conformations of subunit ε is controlled
by the cellular energy status. ATP can trigger the transition into the hair-
pin state, thereby relieving inhibition of ATP hydrolysis [69,78]. Subunit
ε canmonitor cellular ATP levels in twoways, in addition to sensing the
ATP occupancy of the nucleotide binding sites in subunits β subunit ε
has the intriguing ability of directly binding ATP, although lacking typi-
cal ATP-binding domains and motifs [79–83].
The regulatory role of this subunit may vary considerably between
different species, allowing for ﬁne-tuning the activity of ATP synthase
to the physiological needs of each individual species. Accordingly, the
helical domain of subunit ε differs considerably between organisms
[75]. Subunit ε in several anaerobic bacteria such as Chlorobium lack
the C-terminal helical domain, which may facilitate inversion of ATP
synthase function for maintenance of the PMF [75,84]. Mutagenesis
experiments on subunit ε in E. coli did not reveal a distinct role for the
C-terminal helical domain [85] and subunit ε in Bacillus subtilis wasFig. 2. The key regulator subunit ε in mycobacteria. (A) Structure of E. coli ATP synthase
subunit ε in extended state (green) as compared with the hairpin state (red). The struc-
tures were obtained from the Protein Data Bank (PDB IDs 3oaa and 1aqt, respectively).
(B) Sequence alignment of mycobacteria ATP synthase subunit εwith the homologue in
E. coli and in human mitochondria (referred to as subunit δ in mitochondria). Dark blue
indicates conserved across all shown species, red indicates 75% identity, light blue indi-
cates 50% identity. M.tub: M. tuberculosis, M.sme: M. smegmatis, E.col: Escherichia coli,
B. ps3: Bacillus PS3 and H.sap: Homo sapiens. Blue rods below the sequences indicate the
C-terminal α-helices. Boxed region 1 highlights ATP-binding motif region, boxed region
2 indicates the lacking C-terminal α-helix in mycobacteria. (C) Homology model for the
structure ofM. tuberculosis ATP synthase subunit ε (orange) as compared with the struc-
ture of subunit ε from E. coli (green). The homology model was made using the Swiss-
Model server [162] using the structure of E. coli subunit ε (PDB ID 3oaa [62]) as template.reported to relieve inhibition by Mg-ADP [86]. In mycobacteria
the need to prevent excess ATP consumption under low oxygen
tensions may be exceptionally strict, consequently subunit εmay play
an exceptionally important role in order to adapt to the environment
encountered in the human host. Genetic data indicated that while
the N-terminal β-barrel region of subunit ε is largely conserved in
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mitochondria (Fig. 2B), interestingly mycobacteria lack the helix at the
C-terminal tip (Fig. 2B,C). Recently, subunit ε fromM. tuberculosis was
over-expressed and functionally characterized. This subunit was capa-
ble of blocking ATP hydrolysis activity by the isolated catalytic α3β3γ
core from Bacillus PS3, however, it was found unable of binding ATP
[87].
In subunit ε from Bacillus PS3 binding of ATP is facilitated by
the motif I(L)DXXRA (ε88–93), a highly atypical ATP binding motif
(Fig. 2B). In addition, the side chains of three additional arginine resi-
dues (εR100, εR121, and εR125) coordinate the phosphate group of
ATP, with εE83 involved in formation of the adenine-binding pocket
[81]. In the homologous ATP binding motif in mycobacterial subunit ε
the arginine is replaced by alanine (IDEAAA, ε90–95), which may
impede efﬁcient ATP binding. Moreover, mycobacterial subunit ε
lacks the residues corresponding to εR121 and εR125 due to the lacking
C-terminal helix and εR100 is not conserved in mycobacteria (Fig. 2B).
Taken together, these differences may explain the lack of ATP binding
by mycobacterial subunit ε.
As ATP binding facilitates the transition of subunit ε from the extend-
ed inhibitory conformation towards the folded hairpin state, the ob-
served lack of ATP binding may indicate strong, continuous inhibition
of ATP hydrolysis by subunit ε in mycobacteria. In line with this ﬁnding,
lack of ATP-dependency of inhibition has previously been reported for
subunit ε from spinach chloroplast and from the cyanobacterium
Thermosynechococcus elongates [56,88], species, which likemycobacteria
may need to efﬁciently prevent wasteful ATP consumption. However, it
cannot be excluded that the lack of the C-terminal helix allows for only
minor inhibition of ATP hydrolysis in mycobacterial ATP synthase and
that the observed suppression of ATP hydrolysis is caused by other fea-
tures, e.g. in the catalytic core. Additional effectors, as exempliﬁed by
subunit ζ in P. denitriﬁcans and other α-proteobacteria [89], may also
contribute to activity modulation of mycobacterial ATP synthase.
Mycobacterial subunit εmay constitute an interesting tool for inves-
tigation of the working of bacterial ATP synthase regulation, in particu-
lar the respective contributions of each of the two C-terminal helices as
well as the function of individual amino acid residues in the helical do-
main. Furthermore, in case subunit ε is responsible for the observed
suppression of ATP hydrolysis by mycobacterial ATP synthase, activa-
tion of the “latent” ATP hydrolysis functionality could constitute an
attractive approach for development of new antibacterial entities.
This subunit may serve as an interesting epitope for small-molecule
compounds to bind and to stimulate ATP hydrolysis. Fragment-based
approaches for drug discovery [90] may provide small-molecules mim-
icking the lacking C-terminal tip of subunit ε, potentially relieving its in-
hibitory effect. Activators speciﬁc for mycobacterial ATP synthase may
have the ability to deplete bacterial ATP pools and may represent pow-
erful drugs, in particular on bacteria in metabolic states with low cellu-
lar energy reserves.
3. Coupling proton ﬂow with ATP synthesis
M. tuberculosis can survive with a low PMF of−110 mV [18], sug-
gesting that ATP synthase needs to be adapted for efﬁcient energy
usage and is able of using this low proton motive force for synthesis of
ATP. Activity of ATP synthase signiﬁcantly depends on the PMF, with
considerable variation between different organisms [91]. As hypothe-
sized previously, ATP synthase ofM. tuberculosismay turn out to be ac-
tive at lower PMF as compared to most bacteria or mitochondria [19].
This ability apparently is closely linked to the proton translocating sub-
unit c. Subunit c is an integral membrane protein, which consists of two
transmembrane helices. This subunit assembles as an oligomeric ring,
with the N-terminal helix (helix 1) located towards the center of the
ring and the C-terminal helix (helix 2) facing the outside. Protons from
the periplasmatic side of the membrane can bind the carboxylate side
chain of a highly conserved acidic residue located in the membrane-spanning region of helix 2 (cD61 in E. coli, cE61 in M. tuberculosis)
[92,93]. This protonation allows rotational movement of the c-ringwith-
in the hydrophobic core region of themembrane, after which the proton
is released into the cytoplasm [94,95]. The number of subunit c mono-
mers in the c-ring apparently is ﬁxed in a given species, but this stoichi-
ometry varies considerably between different species as detailed below.
Whereas 10 monomers have been found in c-rings from E. coli and
Bacillus PS3 [96,97] in the alkaliphilic Bacillus sp. strain TA2.A1, which
has to cope with a low PMF under alkaline conditions, the subunit
c complex is composed of 13 monomers [98,99]. A larger number of
monomers per subunit c oligomer may increase the H+/ATP ratio and
thus facilitate proton ﬂow and synthesis of ATP under low PMF condi-
tions [98]. No structural data are available for the c-ring from human
mitochondria, however, in ATP synthase from bovine heart mitochon-
dria, eight monomers were found in the c-ring [100]; conceivably, the
human homologue may show the same stoichiometry.
For mycobacteria the number of monomers in the c-ring is un-
known. However, as mycobacterial ATP synthase has to cope with a
low PMF in order to synthesize ATP, mycobacteria may employ a strat-
egy similar to alkaliphilic bacteria. A large c-ring (number likely N10)
would allocate more steps of subunit c to the synthesis of one ATP,
supporting production of ATP at low PMF. A comparison of c-rings
from several cyanobacterial species revealed that subtle sequence dif-
ferences apparently determine the oligomeric state of the c-ring [101].
In Ilyobacter tartaricus, directed mutagenesis of a glycine-repeat motif
in helix 1 of subunit c, cG25–G33, allowed for engineering of c-rings
with deﬁned stoichiometry (12 instead of 11 monomers) [102]. The
mutants with increased numbers of monomers in the c-ring indeed
displayed higher activity at lower PMF, as compared with the wild
type [102]. In mycobacterial subunit c the region containing the
glycine-repeat (cG23–G29 in M. tuberculosis) is conserved, however,
in the ﬂanking regions a higher content of glycine and alanine residues
(e.g. cG19, cG20, cA31) is found as comparedwith the E. coli homologue
(Fig. 3A). Helix 1 is thought to be involved in establishing helix/helix
contacts in the center of the c-ring [102,103]; the large number of
small residues in mycobacterial subunit c may thus facilitate a dense
packing of the monomers in the ring. If the c-ring inM. tuberculosis in-
deed is comprised of N10monomers then a signiﬁcantly different topol-
ogy of this key subunit in proton translocation can be expected as
compared with the human homologue (Fig. 3B).
The c-ring is the target of several small molecule inhibitors, such as
dicylcohexyl carbodiimide, oligomycin and venturicidin [104–107].
Dicylcohexyl carbodiimide directly binds to the conserved acidic resi-
due located in the central part of helix 2 of the c-ring. For venturicidin
no structural data are available, mutations inﬂuencing venturicidin
sensitivity have been mapped to the membrane-spanning part of helix
1 in subunit c (G24 and A27 in S. cerevisiae) [108]. Recently, the struc-
ture of the c-ring from yeast mitochondria complexed with oligomycin
has been determined [107]. Olimomycin makes contact with the car-
boxyl side chain of the essential acidic residue in helix 2 (Glu59 in
S. cerevisiae), with the bulk of the inhibitor bound via hydrophobic
interactions to the membrane-spanning regions of subunit c. As the
oligomycin binding site overlaps with residues involved in resistance
to venturicidin and ossamycin, a common drug-binding niche in the
central part of subunit c was proposed [107]. Whereas DCCD is a non-
selective inhibitor that blocks ATP synthase function in many species,
oligomycin displays increased afﬁnity for eukaryotic ATP synthases as
compared with bacterial ones [107].
The diarylquinolines represent a class of ATP synthase inhibitors
that selectively inhibit ATP synthase in mycobacteria by binding to sub-
unit c [27,28,109]. Diarylquinolines are potent antibacterials that effec-
tively kill M. tuberculosis [26]. The lead compound of this drug class,
bedaquiline, has recently received approval from the US Food & Drug
Administration [110,111]. Residues in mycobacterial ATP synthase im-
portant for sensitivity to bedaquiline are located in themembrane span-
ning part of subunit c, both in helix 1 (cD28) as well as in helix 2 (cL59,
Fig. 3. The proton translocating subunit c inmycobacteria. (A) Sequence alignment of ATP
synthase subunit c in mycobacteria compared with the homologue from E. coli and from
human mitochondria. Dark blue indicates conserved across all shown species, red indi-
cates 75% identity, light blue indicates 50% identity. M.tub: M. tuberculosis, M.sme:
M. smegmatis, E.col: Escherichia coli and H.sap: Homo sapiens. Blue rods below the se-
quences indicate the two membrane-spanning α-helices. Box region 1 highlights the
highly conserved glycine-repeat region in mycobacteria. Box region 2 shows cA63 in
mycobacteria, a residue modulating sensitivity for diarylquinolines (B) The structure
(top view) of the c-ring from Arthrospira platensis (15 monomers, cyan) and the c-ring
from bovine heart mitochondria (8 monomers, magenta, 100% sequence identity with
the human homologue). The structures of c-rings from Arthrospira platensis [163] and
from bovine heart mitochondria [100] were obtained from the Protein Data Bank (PDB
IDs 2wie and 2xnd, respectively).
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suggest a deﬁned binding site in subunit c for bedaquiline [28]. Model-
ing studies predict a binding niche for bedaquiline at the interface be-
tween subunit a and subunit c, close to the conserved acidic residue in
helix 2 [115,116]. Alternatively, based on binding studies involvingmy-
cobacterial subunit ε, a binding site for diarylquinolines at the interface
between subunit c and subunit εwas proposed [87].
The molecular basis for the selectivity observed for bedaquiline
[26,109] still needs to be elucidated. Amino acid polymorphisms in the
membrane-spanning part of subunit c may act as key determinants for
size and shape of a putative drug-binding pocket. Replacement of a
small residue inmycobacterial ATP synthase by a bulkier one in less sus-
ceptible ATP synthases such as the E. coli or human mitochondrial ho-
mologue, e.g. substitution of cA63 by an isoleucine in E. coli or by a
methionine in human mitochondria (Fig. 3A), may impose steric hin-
drance on drug binding [109,115]. Bedaquiline likely binds to a niche
overlapping with the oligomycin-binding site [107]. In both cases the
hydrophilic parts of the inhibitors may interact with the essential acidic
residue in helix 2, providing speciﬁcity, whereas the hydrophobic bulk
makes extensive van-der-Waals contacts and/or π–π interactions with
the adjacent unipolar residues, enhancing the free binding energy.
As mentioned above, spontaneous mutations in mycobacterial ATP
synthase can decrease sensitivity for diarylquinolines [26,114]. These
mutants retain their ﬁtness under optimal growth conditions [27], how-
ever, they have not been systematically characterized for ﬁtness underconditions mimicking the environment in the human host. As such, it
is unknown if ATP synthase in the mutated mycobacterial strains re-
mains fully functional under conditions of physiological stress. The
polymorphisms may at least in part represent adaptations needed for
optimal (long-term) survival chances for M. tuberculosis in the human
host.
Polymorphisms in subunit c may not only directly contribute to
a drug-binding site, but may also affect the general structure of the
c-ring, thereby indirectly inﬂuencing the drug-binding site. This has
been proposed for resistance mutations against oligomycin in helix 1
of subunit c, which are located at the inner surface of the c-ring, where-
as the inhibitor binds to the outer surface [107]. Similarly, mutations of
cD28, also located in helix 1, may inﬂuence the general structure of
the binding pocket for diarylquinolines. As polymorphisms/pointmuta-
tions can even change the oligomeric state of the c-ring [102] they may
in this way contribute to shaping the surface curvature of the c-ring and
concomitantly modulate potential binding sites for small molecule in-
hibitors (Fig. 3B). As an example, cD28 in M. tuberculosis is located in
the glycine-rich stretch thought to be involved in helix/helix contacts
(Fig. 3A), mutations at this position may inﬂuence the density of helix
packing or even the oligomeric state of the c-ring.
Next to the protein components of the proton-translocatingmachin-
ery in ATP synthase in addition lipidsmay play an important role for ATP
synthase function and potentially also for drug binding. Lipids bound to
distinct sites in oligomericmembrane proteins can contribute to protein
stability and regulation. As an example, cardiolipin has been shown
to closely interact with respiratory complexes in mitochondria [117]
and this lipid activates puriﬁed ATP synthase from yeast [118]. The
cytoplasmatic membrane in mycobacteria displays an unusual lipid
composition with a large percentage of cardiolipin and less phosphati-
dyl glycerol, as compared with other bacteria [119]. The importance of
lipids, in particular of cardiolipin, in mycobacterial energy metabolism
needs to be investigated.
The c-ring is closely connected to subunit γ, which connects the
Fo rotary motor to the nucleotide binding sites in the α3β3 catalytic
unit. Subunit γ consists of an extended coiled-coil made up by the
N-terminal and C-terminal helical regions, which penetrates into
the cavity of the α3β3 hexamer [5], and a globular mixed helical/sheet
domain, which is located at the bottom, close to the c-ring (Fig. 4A)
[62,120]. The coiled-coil region displays a higher degree of sequence
identity/similarity among across species than the mixed globular
domain. This likely reﬂects evolutionary constraints in closely ﬁtting
the coiled-coil region into the α3β3 cavity, whereas the bottom part of
subunit γ may need to be adapted to the size and oligomeric state of
the c-ring in each particular organism. Subunit γ from M. tuberculosis
shows 37% and 25% similarity compared with its homologue E. coli
and in human mitochondria, respectively (Fig. 4B) [121]. In line with
ﬁndings on other species, the highest degree of sequence similarity is
found in the N-terminal and C-terminal coiled-coil region (Fig. 4B).
γM23 (E. coli numbering) is located at the interface with subunit β
[5]. Its substitution by lysine in E. coli and Rhodobacter capsulatus strong-
ly impeded catalysis [48,122]. It has been suggested that the mutation
arrests subunit γ due to electrostatic interaction with the DELSEED se-
quence in subunit β and that the PMF can activate ATP synthase from
this arrested state [48]. In mycobacteria γM23 is replaced by a gluta-
mine (γQ24 inM. tuberculosis) (Fig. 4B), which may potentially allow
for formation of hydrogen bonds with the DELSEED sequence. If so,
such an interactionmay contribute to suppression of ATP hydrolysis ac-
tivity in the absence of a PMF and may form an important element for
regulation of ATP synthesis in mycobacteria.
Subunit γ from mycobacteria displays a unique insertion of 13
amino acid residues, γG165–D178 in M. tuberculosis, which is not
present in known prokaryotic or eukaryotic homologues (Fig. 4A,B).
NMR spectroscopy of a synthesized peptide corresponding to γG165–
D178 indicated that this insert forms a loop of polar residues. Modeling
of the peptide into the high-resolution structure of F1 from E. coli
Fig. 4. The rotating subunit γ in mycobacteria. (A) Homology model for the structure ofM. tuberculosis ATP synthase subunit γ (yellow) superimposed on the structure from the E. coli
homologue (blue). Lower part:magniﬁcation of themixed helical/sheet domainwith the unique insertion of 13 amino acid residues inM. tuberculosis (red loop). The black arrow indicates
the location of the regulatory insert found in photosynthetic ATP synthases. The homologymodel wasmade using the Swiss-Model server [162]. The structure of E. coli subunit γ [62] was
obtained from the Protein Data Bank (PDB ID 3oaa). (B) Sequence alignment ofmycobacteria ATP synthase subunit γwith the homologue in E. coli and in humanmitochondria. Dark blue
indicates conserved across all shown species, red indicates 75% identity, light blue indicates 50% identity. M.tub:M. tuberculosis, M.sme:M. smegmatis, E.col: Escherichia coli and H.sap:
Homo sapiens. Blue rods below the sequences indicate the coiled-coil α-helices. Boxed region 1 shows the residue γ24 (M. tuberculosis numbering) thought to be involved in contact
with subunit β. Boxed region 2 highlights the unique insertion found in mycobacteria subunit γ.
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subunits c [121]. Due to the presence of largely polar and highly acidic
residues, γG165–D178 might interact with residues cR41, cQ42, cE44
and Q46 in the cytoplasmic loop between helices 1 and 2 of subunit c.
For this loop of subunit c a function in gating of proton ﬂow has been
proposed [123]. cQ46 (replaced by an unpolar isoleucine in E. coli) has
been proposed to interact with γE169 and γD170, enhancing the inter-
action between γ165–178 and the c-ring [121]. Alternatively it can be
speculated that an additional connection between subunit γ and the
c-ring, as potentially provided by the mycobacterial insert γG165–
D178, may modulate the elastic properties of the γ/c rotating unit and
as such improve the efﬁciency of the mycobacterial enzyme. Subunit γ
has previously been pinpointed as a central elastic element in ATP syn-
thase, coupling the non-integer ratio of proton transfer across subunit cwith synthesis or hydrolysis of ATP in the catalytic sites [124,125]. If
γG165–D178 plays a speciﬁc role in activity, stability or assembly of
mycobacteria, it may prove a promising target for small-molecule com-
pounds to bind and to regulate the enzyme's activity.
γG165–D178 is located about 30 residues from the insert in photo-
synthetic organisms that allows for adjusting ATP synthase activity in
response to environmental light intensity [126,127]. This regulatory in-
sert (γ194–230 in spinach chloroplast) enables redox regulation of ATP
synthase in plant chloroplasts [126], whereas in cyanobacteria it modu-
lates inhibition by subunit ε, but does not facilitate redox-regulation
[88]. Although both γG165–D178 and the insert in photosynthetic or-
ganisms are part of the mixed domain of subunit γ, sequence/structure
data suggest they are located at opposite ends of one β-strand (Fig. 4A).
These locationsmay reﬂect the likely respective roles of interactionwith
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insert). The regulatory insert from spinach chloroplast ATP remains
functional when introduced into ATP synthases from other species
[128,129]. It would be interesting to test whether the mycobacterial in-
sert can be transferred across species as well and to evaluate the impact
of the insertion on enzyme stability and functionality.
Subunit γ occupies a central position in ATP synthase. This pivotal
function may predetermine subunit γ, next to subunit ε, for special fea-
tures assisting in optimizing efﬁciency during rotary catalysis.
4. The unusual stator stalk in mycobacteria
The non-rotating parts of F1 (α3β3) and Fo (subunit a) need to be
well connected in order to prevent unproductive rotation of the whole
ATP synthase complex during catalysis. This task is carried out by the
stator stalk, an extended, largely hydrophilic structure at the periphery
of the ATP synthase complex. Inmost bacteria the stator stalk comprises
subunit δ, which is located on top of the α3β3 hexamer, and a dimeric
subunit b, which connects to δ and then reaches all the way down into
the cytoplasmic membrane (Fig. 1A). In the mitochondrial enzyme,Fig. 5. The unusual stator stalk in mycobacteria. (A) Sequence alignment of mycobacterial ATP
subunits in E. coli (subunit b), Anabaena variabilis (subunit b′) and in humanmitochondria (sub
light blue indicates 50% identity. M.tub: M. tuberculosis, M.sme: M. smegmatis, E.col: Escher
ofmycobacteria ATP synthase subunit b/δ (C-terminal part) with the homologue in E. coli (
110-residue insertion in mycobacteria.subunit δ is replaced by the homologous oligomycin-sensitivity-
conferring protein (OSCP). In addition, only a single subunit b is
found, accompanied by two smaller subunits called subunit d and F6
(Fig. 1B) (for review see [130–132]. In cyanobacteria, other photosyn-
thetic bacteria and chloroplasts, as well as in the hyperthermophilic
bacterium Aquifex aeolicus two different, but homologous subunits
(called subunit b and subunit b′ in cyanobacteria and subunits I and II
in chloroplasts) substitute for the subunit b homodimer [133–135].
Interestingly, in mycobacteria one of the subunits b is genetically
fused with subunit δ. The two fusion partners are connected by a linker
region of about 110 residues (Figs. 1C, 5A,B) [136,137]. The secondmy-
cobacterial subunit b lacks the C-terminal part typically found in other
species (Fig. 5B), resembling the b′-type subunits in photosynthetic
bacteria. In this paperwe refer to these twomycobacterial ATP synthase
subunits as subunit b/δ and as subunit b′. In subunit b/δ the C-terminus
of the “subunit b part” is fused to the N-terminus of the “subunit δ part”
(Fig. 5A,B). However, in E. coli, the N-terminus of subunit δ is thought to
be located close to the top of theα3β3 hexamer,whereas the C-terminus
of subunit δ has been assigned as contact area with subunit b [138].
Moreover, in ATP synthase from bovine heart, the N-terminus of OSCPsynthase subunits b/δ (N-terminal part)(M.tub1) and b′ (M.tub2) with the homologous
unit b). Dark blue indicates conserved across all shown species, pink indicates 75% identity,
ichia coli, A.var: Anabaena variabilis and H.sap: Homo sapiens. (B) Sequence alignment
subunit δ) and in human mitochondria (OSCP). The boxed region indicates the unique
1215P. Lu et al. / Biochimica et Biophysica Acta 1837 (2014) 1208–1218is not in close proximity to the C-terminus of subunit b [139]. Likely, the
110-residue linker region in the mycobacterial b/δ fusion allows for the
connection of the two fusion partners [137].
An asymmetric stator stalk may have several potential advantages.
For photosynthetic bacteria it has been suggested that subunit b′ may
be an adaptation to optimize binding to F1 or Fo. The regions of subunits
b and b′ that are not involved in dimer formation may adopt different
conformations and in this way improve interaction with the asymmet-
ric subunit a and/or subunit δ [140]. In mycobacteria the b/δ fusion
and thepresence of subunit b′may serve a similar purpose. This hypoth-
esis has recently been supported by the generation of a chimeric E. coli
ATP synthase carrying E. coli subunit b and subunit δ, which were
connected by the b/δ linker region obtained from Mycobacterium
vanbaalenii [137]. These experiments showed the presence of one b/δ
fusion without the additional b- or b′-type subunit is not sufﬁcient for
proper functional holoenzyme assembly, extending previous work on
the cyanobacterium Synechocystis PCC6803, where deletion of subunit
b′ was lethal [141]. Deletion experiments using the same chimeric
E. coli ATP synthase revealed that the b/δ fusion is responsible for bind-
ing to the α3β3 hexamer, whereas the shorter b′-type subunit is re-
quired for connection with Fo [137]. The N-terminus of the b′-type
subunit in mycobacteria shows an extension of ~25 residues as com-
pared with the b/δ fusion (Fig. 5B), this extension may help in optimiz-
ing binding to the Fo part. Specialization between two subunits b, even
in a homodimer, has been reported earlier based on different interaction
with F1 [142], an offset topology of the two subunit b copies [143,144],
an asymmetric location relative to subunit a [145,146] and the necessity
of the membrane spanning b′, but not its hydrophilic part, for ATP syn-
thase assembly [141]. Taken together, these ﬁndings underscore the
view of extensive specialization between two (different) b-type sub-
units in ATP synthase, a principle for which the mycobacterial enzyme
may represent a prime example. Additionally, or alternatively, the b/δ
fusion may increase the stiffness of the stator stalk, thereby improving
power transmission within the ATP synthase complex. The presence of
two different types of subunit b may also improve the mutual interac-
tion between the two subunits, which form a closely intertwined
coiled-coil [147,148].
The stator stalk fulﬁlls a key role in this complex and dynamic
enzyme, blocking its function most likely inactivates in ATP synthase.
Efforts to ﬁnd enzyme inhibitors usually are directed at blocking the ac-
tive site or other dynamic parts of a target enzyme, not the rigid, static
regions. However, considerable dynamics have been proposed for the
stator stalk, to balance movements related to rotary catalysis [149]. It
is unclear if (potential) dynamics of the stator stalk in the future can
be exploited for inhibition by small molecules and if the subtle differ-
ences in stator stalk composition between prokaryotic and eukaryotic
systems allow for selective inactivation of stator stalk function in bacte-
ria. However, insight in stator stalk function in ATP synthase may in ad-
dition to the added value in basic knowledge, based on the homology
observed between stator stalk subunits and components of bacterial se-
cretions systems [136], also provide input for understanding of the com-
plex and elaborate secretion systems in a variety of pathogenic bacteria.
5. Concluding remarks
Further investigations are required to gain insight into the working
of the peculiar ATP synthase inmycobacteria. Over-production, puriﬁca-
tion and mutagenesis strategies need to be developed to characterize
this protein in isolated form and to link unusual amino acid sequences
to specialized function or adaptation.
The spectrum of antibacterials blocking energy metabolism, in
particular in mycobacteria, is expected to expand in the near future,
with small-molecules inhibitors targeting different components of the
mycobacterial oxidative phosphorylation reported [19,20]. This in-
cludes inhibitors of the type-II NADH dehydrogenase [150,151], the cy-
tochrome bc1 complex [152,153], and compounds interfering with thePMF [154,155]. Moreover, energy metabolism has been validated as
target of antibacterials in non-mycobacterial Gram-positive bacteria,
such as Staphylococcus aureus and Streptococcus pneumoniae, with
diarylquinoline-type inhibitors showing pronounced activity on
Staphylococcus bioﬁlms [156]. High-resolution structures of (parts of)
mycobacterial ATP synthase with bound drugs are needed in order to
gain insight into the mode of drug binding and to understand drug se-
lectivity. New small-molecule entities acting on energy metabolism
may not be restricted to enzyme inhibitors, butmay also include activa-
tors, e.g. for depletion of cellular ATP pools by activation of latent ATP
hydrolysis activity or by re-routing of electron ﬂow to reactive oxygen
species as reported for clofazimine [151].
ATP synthase and the related V-type ATPases are highly dynamic
proteins whose rotary catalysis has been extensively characterized
using a variety of single molecule techniques [6,8,157–160]. Single
molecule analysis of inhibitors bound to ATP synthase may provide
valuable insight into the modes of drug/target interaction, as recently
demonstrated for inhibition of ATP synthase from Bacillus PS3 by
dicylcohexylcarbodiimide [161].
Elucidating the working of ATP synthase from pathogenic bacteria
can not only contribute to improved insight into the general working
of this enzyme, butmay also revealmolecular adaptations to the speciﬁc
environments. A better understanding of these adaptations in patho-
genic bacteria and of the differences as compared with the human
homologuemay provide input for a knowledge-based design of new in-
hibitors blocking ATP synthase or other components of bacterial energy
metabolism.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbabio.2014.01.022.
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